With news today
$FOXO Technologies(FOXO.US$FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy
$Bit Digital(BTBT.US$Bit Digital, Inc. Launches New AI Business: Secures Customer Contract Worth up to $257 Million, Procures NVIDIA H100 GPU
$Meta Materials(MMAT.US$Meta Materials Appoints Ms. Jennifer Cheraso as Chief Human Resources Officer
$INVO Bioscience(INVO.US$INVO Bioscience
and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
$Ambrx Biopharma(AMAM.US$Ambrx Announces ARX517, a PSMA-Targeted ADC, Demonstrates a Promising 52% PSA50 (≥50% Reduction) and a Highly Differentiated Safety and PK Profile in Patients with mCRPC, who Progressed on Multiple FDA-Approved Treatments
$Wearable Devices(WLDS.US$Wearable Devices Expands Mudra Licensing Program to Include Defense and Military Applications
$Inpixon(INPX.US$Inpixon Announces Planned Spin-off and Merger of SAVES UK Business with Damon Motors Inc., Makers of the Award Winning HyperSport Electric Motorcycle, and Plans for Nasdaq Listing of Combined Company
$Ault Alliance(AULT.US$Ault Alliance Announces Preliminary Third Quarter Revenue of Over $52.5 MillionAult Alliance Announces Preliminary Third Quarter Revenue of Over $52.5 Million
$Mullen Automotive(MULN.US$Mullen Provides Update on Lawsuit Against TD Ameritrade, Charles Schwab, National Finance Services and Others
$EngageSmart(ESMT.US$ EngageSmart Agrees to Be Acquired by Vista Equity Partners for $4.0 Billion
$NOCO-NOCO(NCNC.US$ noco-noco to Acquire X-SEPA™ Separator and Lithium-ion Battery Development Company noco-tech
$Navios Maritime Holdings(NM.US$ Navios Maritime Holdings Inc. Announces Definitive Merger Agreement
$Aclarion(ACON.US$ ACONW - Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan
$TC BioPharm(TCBP.US$ Announces Submission of IND Application to U.S. FDA for Treatment of Relapse/Refractory AML
“Filing is supported by strong clinical data and IND enabling pre-clinical data associated withTCB-008 in treatment of Acute Myeloid Leukemia”https://www.prnewswire.com/news-releases/tc-biopharm-announces-submission-of-investigational-new-drug-ind-application-to-us-fda-for-treatment-of-relapserefractory-aml-301962901.html
“Filing is supported by strong clinical data and IND enabling pre-clinical data associated withTCB-008 in treatment of Acute Myeloid Leukemia”https://www.prnewswire.com/news-releases/tc-biopharm-announces-submission-of-investigational-new-drug-ind-application-to-us-fda-for-treatment-of-relapserefractory-aml-301962901.html
$CEL-SCI(CVM.US$ 5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
I’m instinct based traders , I hate reading charts !
My prediction is magic!
6101Followers
135Following
186KVisitors
Follow
Quah : hmm is that good news for foxo? it sounds decent?
AlvinnnnnnngeniusOP Quah: Can try the price is quite bottoms
AlvinnnnnnngeniusOP Quah: But I like Ault and btbt more
Quah : thanks